Expert-Level Diagnosis of Nonpigmented Skin Cancer by Combined Convolutional Neural Networks
- PMID: 30484822
- PMCID: PMC6439580
- DOI: 10.1001/jamadermatol.2018.4378
Expert-Level Diagnosis of Nonpigmented Skin Cancer by Combined Convolutional Neural Networks
Abstract
Importance: Convolutional neural networks (CNNs) achieve expert-level accuracy in the diagnosis of pigmented melanocytic lesions. However, the most common types of skin cancer are nonpigmented and nonmelanocytic, and are more difficult to diagnose.
Objective: To compare the accuracy of a CNN-based classifier with that of physicians with different levels of experience.
Design, setting, and participants: A CNN-based classification model was trained on 7895 dermoscopic and 5829 close-up images of lesions excised at a primary skin cancer clinic between January 1, 2008, and July 13, 2017, for a combined evaluation of both imaging methods. The combined CNN (cCNN) was tested on a set of 2072 unknown cases and compared with results from 95 human raters who were medical personnel, including 62 board-certified dermatologists, with different experience in dermoscopy.
Main outcomes and measures: The proportions of correct specific diagnoses and the accuracy to differentiate between benign and malignant lesions measured as an area under the receiver operating characteristic curve served as main outcome measures.
Results: Among 95 human raters (51.6% female; mean age, 43.4 years; 95% CI, 41.0-45.7 years), the participants were divided into 3 groups (according to years of experience with dermoscopy): beginner raters (<3 years), intermediate raters (3-10 years), or expert raters (>10 years). The area under the receiver operating characteristic curve of the trained cCNN was higher than human ratings (0.742; 95% CI, 0.729-0.755 vs 0.695; 95% CI, 0.676-0.713; P < .001). The specificity was fixed at the mean level of human raters (51.3%), and therefore the sensitivity of the cCNN (80.5%; 95% CI, 79.0%-82.1%) was higher than that of human raters (77.6%; 95% CI, 74.7%-80.5%). The cCNN achieved a higher percentage of correct specific diagnoses compared with human raters (37.6%; 95% CI, 36.6%-38.4% vs 33.5%; 95% CI, 31.5%-35.6%; P = .001) but not compared with experts (37.3%; 95% CI, 35.7%-38.8% vs 40.0%; 95% CI, 37.0%-43.0%; P = .18).
Conclusions and relevance: Neural networks are able to classify dermoscopic and close-up images of nonpigmented lesions as accurately as human experts in an experimental setting.
Conflict of interest statement
Figures




Comment in
-
MUW researcher of the month.Wien Klin Wochenschr. 2019 Nov;131(21-22):582-583. doi: 10.1007/s00508-019-01580-1. Wien Klin Wochenschr. 2019. PMID: 31713738 No abstract available.
Similar articles
-
Computerizing the first step of the two-step algorithm in dermoscopy: A convolutional neural network for differentiating melanocytic from non-melanocytic skin lesions.Eur J Cancer. 2024 Oct;210:114297. doi: 10.1016/j.ejca.2024.114297. Epub 2024 Aug 25. Eur J Cancer. 2024. PMID: 39217816
-
Assessment of Diagnostic Performance of Dermatologists Cooperating With a Convolutional Neural Network in a Prospective Clinical Study: Human With Machine.JAMA Dermatol. 2023 Jun 1;159(6):621-627. doi: 10.1001/jamadermatol.2023.0905. JAMA Dermatol. 2023. PMID: 37133847 Free PMC article.
-
Man against machine reloaded: performance of a market-approved convolutional neural network in classifying a broad spectrum of skin lesions in comparison with 96 dermatologists working under less artificial conditions.Ann Oncol. 2020 Jan;31(1):137-143. doi: 10.1016/j.annonc.2019.10.013. Ann Oncol. 2020. PMID: 31912788
-
How to diagnose nonpigmented skin tumors: a review of vascular structures seen with dermoscopy: part I. Melanocytic skin tumors.J Am Acad Dermatol. 2010 Sep;63(3):361-74; quiz 375-6. doi: 10.1016/j.jaad.2009.11.698. J Am Acad Dermatol. 2010. PMID: 20708469 Review.
-
Skin cancer classification via convolutional neural networks: systematic review of studies involving human experts.Eur J Cancer. 2021 Oct;156:202-216. doi: 10.1016/j.ejca.2021.06.049. Epub 2021 Sep 8. Eur J Cancer. 2021. PMID: 34509059
Cited by
-
Evaluation of Melanoma Thickness with Clinical Close-up and Dermoscopic Images Using a Convolutional Neural Network.Acta Derm Venereol. 2022 Oct 11;102:adv00790. doi: 10.2340/actadv.v102.2681. Acta Derm Venereol. 2022. PMID: 36172695 Free PMC article.
-
Development and validation of a deep learning model for improving detection of nonmelanoma skin cancers treated with Mohs micrographic surgery.JAAD Int. 2023 Nov 7;14:39-47. doi: 10.1016/j.jdin.2023.10.007. eCollection 2024 Mar. JAAD Int. 2023. PMID: 38089398 Free PMC article.
-
Artificial Intelligence Applied to Non-Invasive Imaging Modalities in Identification of Nonmelanoma Skin Cancer: A Systematic Review.Cancers (Basel). 2024 Feb 1;16(3):629. doi: 10.3390/cancers16030629. Cancers (Basel). 2024. PMID: 38339380 Free PMC article. Review.
-
MUW researcher of the month.Wien Klin Wochenschr. 2019 Nov;131(21-22):582-583. doi: 10.1007/s00508-019-01580-1. Wien Klin Wochenschr. 2019. PMID: 31713738 No abstract available.
-
Automatic Triage of 12-Lead ECGs Using Deep Convolutional Neural Networks.J Am Heart Assoc. 2020 May 18;9(10):e015138. doi: 10.1161/JAHA.119.015138. Epub 2020 May 14. J Am Heart Assoc. 2020. PMID: 32406296 Free PMC article.
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical